Related Experiment Video
Updated: Feb 2, 2026

Identification of Circular RNAs using RNA Sequencing
Published on: November 14, 2019
ADAR2-dependent A-to-I RNA editing in the extracellular linear and circular RNAs
Takashi Hosaka1, Takenari Yamashita2, Sayaka Teramoto3
1Department of Neurology, Division of Clinical Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, 305-8575, Japan; Graduate School of Medicine, University of Tokyo, Bunkyo-ku, Tokyo, 113-0033, Japan.
Abstract:
Currently, no reliable biomarkers of amyotrophic lateral sclerosis (ALS) exist. In sporadic ALS, RNA editing at the glutamine/arginine site of GluA2 mRNA is specifically reduced in the motor neurons due to the downregulation of adenosine deaminase acting on RNA 2 (ADAR2). Furthermore, TDP-43 pathology, the pathological hallmark of ALS, is observed in the ADAR2-lacking motor neurons in ALS patients and conditional ADAR2 knockout mice, suggesting a pivotal role of ADAR2 downregulation in the ALS pathogenesis. Extracellular RNAs were shown to represent potential disease biomarkers and the editing efficiencies at their ADAR2-dependent sites may reflect cellular ADAR2 activity, suggesting that these RNAs isolated from the body fluids may represent the biomarkers of ALS. We searched for ADAR2-dependent sites in the mouse motor neurons and human-derived cultured cells and found 10 sites in five host RNAs expressed in SH-SY5Y cells and their culture medium. Of these, the arginine/glycine site of SON mRNA was newly identified as an ADAR2-dependent site. Furthermore, we detected a circular RNA with an ADAR2-dependent site in the SH-SY5Y cells and their culture medium. Therefore, the changes in the editing efficiencies at the identified host RNA sites isolated from the body fluids may represent potential biomarkers of ALS.
Insights
Researchers identified new RNA editing sites linked to amyotrophic lateral sclerosis (ALS). Changes in these adenosine deaminase acting on RNA 2 (ADAR2)-dependent sites in extracellular RNAs could serve as novel ALS biomarkers.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Amyotrophic lateral sclerosis (ALS) lacks reliable biomarkers.
- Reduced RNA editing at the GluA2 Q/R site in motor neurons is linked to ADAR2 downregulation in sporadic ALS.
- TDP-43 pathology, common in ALS, is found in ADAR2-deficient motor neurons, suggesting ADAR2's role in ALS pathogenesis.
Purpose of the Study:
- To identify novel ADAR2-dependent RNA editing sites.
- To explore the potential of extracellular RNA editing efficiencies as ALS biomarkers.
- To investigate ADAR2 activity in relation to ALS.
Main Methods:
- Searched for ADAR2-dependent sites in mouse motor neurons and human SH-SY5Y cells.
- Analyzed RNA editing efficiencies in host RNAs and circular RNAs.
- Investigated RNAs in cell culture medium to mimic extracellular detection.
Main Results:
- Identified 10 ADAR2-dependent sites in five host RNAs in SH-SY5Y cells and their medium.
- Newly identified the arginine/glycine site of SON mRNA as ADAR2-dependent.
- Detected a circular RNA with an ADAR2-dependent site in cells and medium.
Conclusions:
- Changes in RNA editing efficiencies at identified sites in extracellular RNAs may serve as potential ALS biomarkers.
- ADAR2-dependent RNA editing sites offer a new avenue for ALS biomarker discovery.
- Monitoring extracellular RNA editing could reflect cellular ADAR2 activity and ALS status.
Related Concept Videos
RNA Editing
Circular Shaft - Stresses in Linear Range
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
piRNA - Piwi-interacting RNAs
lncRNA - Long Non-coding RNAs
RNA Stability

